Cough is prevalent in patients with progressive pulmonary fibrosis (PPF) and significantly affects their quality of life.

Participants also completed the Cough Quality of Life Questionnaire (CQLQ) to measure the impact of cough on daily life, and a cough severity visual analogue (VAS) scale to measure cough severity.

Manchester Cough in Lung Cancer Scale (range 1 - 50, with a high score representing worse cough impact) 25.2: 21.7: 19.5: 0.001: Visual Analogue Scale (high score represents worse severity) 57.0 ...

Cough Data. Secondary endpoints focused on cough showed significant improvements, namely: A reduction of 23.6 mm from baseline in the cough visual analogue scale (VAS) (p = 0.0005, 95% CI -35.22 ...

Management should follow existing guidelines, including the recent French recommendations for chronic cough. A visual analog scale can be used, and possible complications should be assessed.

A phase 2a trial of camlipixant, a selective P2X3 receptor antagonist, found that while the drug did not significantly reduce ...

Similarly, high-certainty evidence revealed a 6.2-mm decrease (95% CI -4.1 to -8.4) in cough severity on the 100-mm visual analog scale (VAS). Findings were published simultaneously in JAMA ...

For secondary outcomes, nebulizer and lidocaine throat spray cough treatments reduced the urge-to-cough and cough severity visual analog scale scores compared with placebo (P < .05).